PT KALBE FARMA TBK. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,400 IDR | -1.06% |
|
-5.41% | -13.04% |
| Apr. 01 | PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 20 | Nomura Adjusts Kalbe Farma’s Price Target to IDR1,850 From IDR2,500, Keeps at Buy | MT |
Evolution of the average Target Price on PT Kalbe Farma Tbk.
Price target over the last 5 years
History of analyst recommendation changes
982471a9d41970d1552a8feb16c7.e5kqOuomPPXZHmH3Rt7AfZdl-ddENAEGOH5Eb8HLQuY.StpAC99Mc6-sZyalfqulTcchqacge1dtQRcIVrCNKo8C_GVJnExdxOBPAg~4737b3c3e83f78d37c8870b8f2780212
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
1,415
IDR
Average target price
1,777
IDR
Spread / Average Target
+25.56%
High Price Target
2,800
IDR
Spread / Highest target
+97.88%
Low Price Target
1,550
IDR
Spread / Lowest Target
+9.54%
Consensus detail
Consensus revision (last 18 months)
Analysts covering PT Kalbe Farma Tbk.
| Nomura |
Trading Rating
Investor Rating
ESG Refinitiv
B+
EPS Revisions
- Stock Market
- Equities
- KLBF Stock
- Consensus PT Kalbe Farma Tbk.
